Raadi | Blue Cross MN

Soo bandhiga 1821 - 1830 ee natiijooyinka 4296

Bixiye

P83-20 eviCore Healthcare Specialty Utilization Management (UM) Program - Laboratory Management Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Nov 02, 2020

Bixiye

P77-20 2021 Medicare Product Acupuncture Benefit Changes

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Nov 02, 2020

Bixiye

P81-20 eviCore Healthcare Specialty Utilization Management (UM) Program - Cardiology and Radiology Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Nov 02, 2020

Bixiye

QP50-19 Pharmacy Benefit Exclusion for Intramuscular Route of Administration Medications

Wax badan akhri

Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2019

Bixiye

QP105-20 Update: EquiClaim to Perform Focused and Limited Hospital Bill Validation (HBV) Services

Wax badan akhri

Taariikhda uu dhaqangalayo barnaamijka: Okt 28, 2020

Bixiye

QP103-20 Commercial Pharmacy Benefit Exclusion for Emtricitabine-Tenofovir Disoproxil Fumarate Tablet 200-300 mg

Wax badan akhri

Taariikhda uu dhaqangalayo barnaamijka: Okt 28, 2020

Bixiye

QP104-20 Update: Cotiviti to Perform Focused and Limited Hospital Bill Validation (HBV) Services

Wax badan akhri

Taariikhda uu dhaqangalayo barnaamijka: Okt 28, 2020

Bixiye

QP99-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Insulin Pump PA with QL

Wax badan akhri

Taariikhda uu dhaqangalayo barnaamijka: Okt 14, 2020

Bixiye

QP96-20 Medical Drug Update for New to Market Inclisiran

Wax badan akhri

Taariikhda uu dhaqangalayo barnaamijka: Okt 14, 2020

Bixiye

QP97-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hemophilia Factor VIII PA with QL

Wax badan akhri

Taariikhda uu dhaqangalayo barnaamijka: Okt 14, 2020